Anthony Francis Martin

Anthony Francis Martin founded TMA Consultants in 2006, where he is working as Managing Partner from 2006 and Anthony Martin Advisory in 2006, where he is working as Managing Partner from 2006.
Dr. Martin also currently works at 1voice 1vision Ltd., as Non-Executive Chairman from 2012, The Martin Reach, as Chairman, Bioconsult Ltd., as Director, and The Institute of Directors (United Kingdom), as Member.
Dr. Martin also formerly worked at Celsis International Ltd., as Chief Executive Officer, Azur Environmental, as Chief Executive Officer, Molecular Probes, Inc., as Chief Executive Officer, Bio-Techne Ltd., as Chief Executive Officer, Immunodiagnostic Systems Holdings Ltd., as Non-Executive Chairman from 2011 to 2014, Sphere Medical Holding Ltd., as Non-Executive Chairman from 2009 to 2015, Molecular Insight Pharmaceuticals, Inc., as Chairman in 2009, Hologic Ltd., as Chairman, NeuTec Pharma Ltd., as Chairman from 1997 to 2003, Sphere Medical Ltd., as Non-Executive Chairman, Wound Solutions Ltd., as Non-Executive Chairman in 2012, Safeguard Biosystems Holdings Ltd., as Chairman, Orthofix Medical, Inc., as Independent Director from 2013 to 2017, Invitrogen Corp., as Director & Head-Molecular Biology Division, Protedyne Corp., as Director, Abcam Plc, as Independent Non-Executive Director from 2012 to 2016, Prelude Trust Plc, as Non-Executive Director, Keysight Technologies UK Ltd., as Director, Phico Therapeutics Ltd., as Non-Executive Director in 2012, Revolo Biotherapeutics Ltd., as Non-Executive Director, GE Healthcare Ltd. (United Kingdom), as Principal, and Molecular Biology Resources, Inc., as President.
Dr. Martin received his undergraduate degree from the University of Huddersfield and doctorate degree from Manchester Medical School.